Stryker Corporation (SYK)
Return on equity (ROE)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 3,246,000 | 2,993,000 | 3,165,000 | 2,358,000 | 1,994,000 |
| Total stockholders’ equity | US$ in thousands | 22,420,000 | 20,634,000 | 18,593,000 | 16,616,000 | 14,877,000 |
| ROE | 14.48% | 14.51% | 17.02% | 14.19% | 13.40% |
December 31, 2025 calculation
ROE = Net income ÷ Total stockholders’ equity
= $3,246,000K ÷ $22,420,000K
= 14.48%
Peer comparison
Dec 31, 2025
Company name
Symbol
ROE
Stryker Corporation
SYK
14.48%
Abbott Laboratories
ABT
28.12%
CONMED Corporation
CNMD
13.76%